ImmunoPrecise Antibodies Gross Margin 2022-2025 | IPA

Current and historical gross margin for ImmunoPrecise Antibodies (IPA) over the last 10 years. The current gross profit margin for ImmunoPrecise Antibodies as of January 31, 2025 is %.
ImmunoPrecise Antibodies Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-01-31 $0.02B $0.01B 52.94%
2024-10-31 $0.02B $0.01B 50.00%
2024-07-31 $0.02B $0.01B 42.11%
2024-04-30 $0.02B $0.01B 42.11%
2024-01-31 $0.02B $0.01B 44.44%
2023-10-31 $0.02B $0.01B 47.06%
2023-07-31 $0.02B $0.01B 50.00%
2023-04-30 $0.02B $0.01B 50.00%
2023-01-31 $0.02B $0.01B 56.25%
2022-10-31 $0.02B $0.01B 56.25%
2022-07-31 $0.02B $0.01B 56.25%
2022-04-30 $0.02B $0.01B 56.25%
2022-01-31 $0.02B $0.01B 62.50%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.021B $0.018B
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.557B 53.26
Tempus AI (TEM) United States $9.312B 0.00
Hims & Hers Health (HIMS) United States $9.304B 97.39
Inspire Medical Systems (INSP) United States $4.724B 73.15
IRhythm Technologies (IRTC) United States $4.334B 0.00
Privia Health (PRVA) United States $2.788B 208.91
Enovis (ENOV) United States $1.951B 12.07
Schrodinger (SDGR) United States $1.898B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.483B 0.00
Omnicell (OMCL) United States $1.428B 30.80
Azenta (AZTA) United States $1.197B 55.74
10x Genomics (TXG) United States $1.053B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.539B 0.00
Talkspace (TALK) United States $0.527B 313.00
Veradigm (MDRX) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.437B 0.00
TruBridge (TBRG) United States $0.393B 0.00
Claritev (CTEV) United States $0.346B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Pulmonx (LUNG) United States $0.144B 0.00
American Well (AMWL) United States $0.114B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.083B 0.00
CareCloud (CCLD) United States $0.074B 3.18
111 (YI) China $0.070B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00